Search research articles
Contact Us
Filters
Showing results (101-110 of 111) with videos related to
Page
of 12
Sort By:
Biochemistry
|
April 14, 1999
Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease
M S Wolfe, W Xia, C L Moore, et al.
BMC Public Health
|
July 29, 2021
Mental health and wellbeing coordinators in primary schools to support student mental health: protocol for a quasi-experimental cluster study
S Darling, G Dawson, J Quach, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 21, 2001
Gamma -secretase inhibitors repress thymocyte development
B K Hadland, N R Manley, D Su, et al.
American Journal of Medical Genetics
|
May 5, 2001
Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 in a boy with a balanced 3;21 translocation
L L Bassett, R C Michaelis, M H Geiger, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 6, 2008
Prospective multicenter evaluation of the pulmonary embolism rule-out criteria
J A Kline, D M Courtney, C Kabrhel, et al.
HIV Medicine
|
September 8, 2015
Hospitalisation rates and associated factors in community-based cohorts of HIV-infected and -uninfected gay and bisexual men
C L Moore, A E Grulich, G Prestage, et al.
Nature Cell Biology
|
July 6, 2000
Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1
W P Esler, W T Kimberly, B L Ostaszewski, et al.
Science (New York, N.Y.)
|
October 5, 1973
Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome
S Goldfischer, C L Moore, A B Johnson, et al.
The Annals of Thoracic Surgery
|
June 1, 1997
Intravenous phenylephrine preconditioning of cardiac grafts from non-heart-beating donors
J T Cope, M C Mauney, D Banks, et al.
Lancet (London, England)
|
June 18, 2013
Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study
, M A Boyd, N Kumarasamy, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 111) with videos related to
Sort By:
Page
of 12
Biochemistry
|
April 14, 1999
Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease
M S Wolfe, W Xia, C L Moore, et al.
BMC Public Health
|
July 29, 2021
Mental health and wellbeing coordinators in primary schools to support student mental health: protocol for a quasi-experimental cluster study
S Darling, G Dawson, J Quach, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 21, 2001
Gamma -secretase inhibitors repress thymocyte development
B K Hadland, N R Manley, D Su, et al.
American Journal of Medical Genetics
|
May 5, 2001
Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 in a boy with a balanced 3;21 translocation
L L Bassett, R C Michaelis, M H Geiger, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 6, 2008
Prospective multicenter evaluation of the pulmonary embolism rule-out criteria
J A Kline, D M Courtney, C Kabrhel, et al.
HIV Medicine
|
September 8, 2015
Hospitalisation rates and associated factors in community-based cohorts of HIV-infected and -uninfected gay and bisexual men
C L Moore, A E Grulich, G Prestage, et al.
Nature Cell Biology
|
July 6, 2000
Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1
W P Esler, W T Kimberly, B L Ostaszewski, et al.
Science (New York, N.Y.)
|
October 5, 1973
Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome
S Goldfischer, C L Moore, A B Johnson, et al.
The Annals of Thoracic Surgery
|
June 1, 1997
Intravenous phenylephrine preconditioning of cardiac grafts from non-heart-beating donors
J T Cope, M C Mauney, D Banks, et al.
Lancet (London, England)
|
June 18, 2013
Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study
, M A Boyd, N Kumarasamy, et al.
Page
of 12